跳至主要内容
临床试验/CTIS2024-511798-31-00
CTIS2024-511798-31-00进行中(未招募)1 期

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100) - 20170543

Amgen Inc.0 个研究点目标入组 932 人开始时间: 2024年2月26日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
932

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Men or women greater than or equal to 18 years old., Pathologically documented, locally-advanced or metastatic malignancy with, KRAS p.G12C mutation identified through molecular testing.

排除标准

  • Active brain metastases from non-brain tumors., Myocardial infarction within 6 months of study day 1., Gastrointestinal (GI) tract disease causing the inability to take oral medication.

研究者

发起方
Amgen Inc.

相似试验

进行中(未招募)
1 期
Clinical study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of AMG 510KRAS p.G12C mutant advanced NSCLC, CRC, and other solid tumorsMedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-001400-11-PTAmgen Inc.733
进行中(未招募)
1 期
Clinical study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of AMG 510
EUCTR2018-001400-11-ROAmgen Inc.733
进行中(未招募)
1 期
Clinical study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of AMG 510KRAS p.G12C mutant advanced NSCLC, CRC, and other solid tumorsMedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2018-001400-11-ATAmgen Inc.791
进行中(未招募)
1 期
Clinical study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of AMG 510
EUCTR2018-001400-11-HUAmgen Inc.733
进行中(未招募)
1 期
Clinical study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of AMG 510
EUCTR2018-001400-11-DEAmgen Inc.733
A Phase 1/2, Study Evaluating the Safety,... | 临床试验